
Web Release Date: March 17,
The First Stereoselective Total Synthesis of Quinine


and
Contribution from the Department of Chemistry, Columbia University, New York, New York 10027
Received December 22, 2000
Abstract:
The first entirely stereoselective total synthesis of (-)-quinine is reported.
Quinine (1)1 has occupied a central place among the many
plant alkaloids which are used in medicine. For over three
centuries, and until relatively recently, it was the only remedy
available to deal with malaria,2 a disease from which millions
have died.3-5
| Figure 1 |
We first put our work in context with a brief survey of some
of the previous synthetic efforts toward quinine. They go back
almost a century and a half. One of the early attempts has
become part of the history and legend of chemistry: the well-known story of William Henry Perkin who, in 1856, when the
empirical formula of quinine, C20H24N2O2, had only recently
been settled, tried to produce the alkaloid by the oxidation of
what was supposedly an N-allyl toluidine (C10H13N) according
to the equation 2(C10H13N) + 3O = C20H24N2O2 + H2O.10
The correct connectivity between the atoms of the quinine molecule was eventually unraveled, largely as the result of the extensive work of the German chemist Paul Rabe,11 who then began to consider the possibility of a synthesis of the alkaloid. This was quite a challenge since the presence of 4 asymmetric carbons in the quinine molecule means that the correct atom connectivity corresponds to 16 possible isomeric structures for the alkaloid. Even without the knowledge of the correct stereochemistry, Rabe chose to attempt to reconstruct quinine from a 3,4-disubstituted piperidine, originally named quinicine, and later known as quinotoxine (3),1a which had earlier been obtained by Pasteur12 by acid-catalyzed isomerization of quinine (Scheme 1). And, indeed, Rabe claimed, in a very terse 1918 com-munication,6 that he had succeeded in accomplishing that partial synthesis.
| Scheme 1 |
Twenty-five years later, Prelog and Pro
tenik13 showed that
the 3-vinyl-4-piperidinepropionic acid, known as homomeroquinene (4), which they had obtained as the proper enantiomer
by degradation of quinotoxine, could be reconverted into the
latter, thereby completing a route from homomeroquinene back
to quinine, assuming the validity of Rabe's claim. A formal
total synthesis of quinine was completed when Woodward and
Doering announced in 19447 that they had succeeded in
synthesizing homomeroquinene itself. As a synthetic route to
quinine, it suffered from the lack of stereocontrol in the
ingenious Woodward-Doering sequence to homomeroquinene,
and from the low yields and the difficult separations of the 4
isomers anticipated from the Rabe scheme for the conversion
of quinotoxine to quinine because that half of the construction
did not involve any stereocontrol.14
| Scheme 2 |
Stereocontrol was not a concern of synthetic organic chemists before 1940 or so, largely because the mechanistic and conformational underpinnings of modern organic chemistry were not yet part of synthesis design. In fact, the configuration of the C-8 and C-9 asymmetric centers of quinine was not yet known in 1918, when Rabe announced the reconstruction of quinine from quinotoxine. By 1944, the cis relationship of the vinyl and propionic acid substituents at positions 3 and 4 of the piperidine ring of homomeroquinene had been established,15 but the Woodward-Doering half of the synthesis was not stereoselective, and produced the precursors of their homomeroquinene target as a mixture of cis and trans stereoisomers, in roughly equal amounts.16
The first successful efforts toward a stereoselective quinine
synthesis were reported 55 years ago.17
A quarter of a century passed before further progress toward
a stereoselective total synthesis of quinine was achieved by
Uskokovi
, Gutzwiller, and their collaborators at Hoffmann-La Roche.8 That impressive achievement was illustrated by a
number of syntheses of quinine in which the quinuclidine ring
was created by forming the bond between N-1 and C-8. That
strategy, which may be called the Rabe connection, was
endorsed by the workers who followed Rabe, starting with
Woodward and Doering,7-9 presumably because of the attractive
structural simplification it seemed to offer.
The problem with that approach, however, turned out to be the difficulty of achieving stereospecificity, or at least high stereoselectivity, involving the C8 and C9 centers, with the result that even the largely stereocontrolled Hoffmann-La Roche synthesis produced quinine together with an equal amount of quinidine (2), that isomer which is epimeric with quinine at both of these centers.
A very important observation was made, however, by the Hoffmann-La Roche chemists who discovered8h that the 1:1 mixture of deoxyquinine (5) and its C-8 epimer, deoxyquinidine (6), which results from one of their syntheses (cf Scheme 2), could be oxidized to a mixture consisting largely of only two of the four possible secondary alcohols, one of them quinine and the other quinidine. They verified the implication of that result by showing that pure deoxyquinine (obtained from natural quinine by C-9 deoxygenation) regenerated quinine under their oxidation conditions. It followed that a stereoselective synthesis of quinine would finally be achieved if a stereospecific synthesis of deoxyquinine could be effected. Such a synthesis became our goal.
We first noted that the formation of the ~1:1 mixture of deoxyquinine (5) and its C-8 epimer (6) mentioned above followed construction of the quinuclidine ring by intramolecular conjugate addition to a 4-alkenylquinoline. In the absence of the vinyl group on the incipient quinuclidine, the two adducts would be mirror images, as would the transition states to their formation. Practically the same situation obtains in the presence of the vinyl group because it can adopt a conformation in which it would have only a minor effect on the relative energies of the transition states to either 5 or 6, thus resulting in equal amounts of these C-8 isomers. A totally different situation would, however, be expected if the C-8 asymmetry arose from closure to a piperidine, rather than to a quinuclidine. Such a scheme would require abandoning the time-honored Rabe connection (shown as a in Figure 2) in favor of the closure shown by b. Adoption of the latter construction would lead to the corollary that the vicinal substituents on the piperidine precursor would now have to be trans. This is not a serious problem, but it leads to the further corollary that the piperidine ring in such a scheme would now have to be trisubstituted because it would bear an additional, and stereodefined, substituent (cf. 7). At first sight, the increase in complexity hardly seemed a step in the right direction.
| Figure 2 |
We concluded, however, that the benefits would be substantial. A major problem with the cis-3,4-disubstituted piperidine intermediates of previous quinine syntheses is that their two possible chair conformations would be similar in energy. Such a situation would make control of stereochemistry difficult to achieve in further transformations. In contrast, trans vicinal substituents on a piperidine intermediate suitable for our purpose would ensure the specific chair conformation in which those substituents are equatorial (cf. 7, Figure 2).
As we will see presently, it was, indeed, the selection of the trisubstituted tetrahydropyridine 7 as our goal that led to the control of the stereochemistry at C-8, and to our stereospecific construction of deoxyquinine.
As starting material for the construction of the 2,4,5-trisubstituted piperidine 7, we chose the known (S)-4-vinylbutyrolactone (8)18,19
Direct alkylation of 4-vinylbutyrolactone (8) with protected iodoethanol derivatives was not as satisfactory as the somewhat more involved, but efficient, process involving opening of the vinyl lactone with diethylamine, protection of the resulting primary hydroxyl as its TBS derivative 9, and alkylation of the resulting diethylamide to give 10. The desired (>20:1) trans-3,4-disubstituted butyrolactone 11 was then readily obtained by selective removal of the TBS group with p-toluenesulfonic acid in ethanol, at room temperature, followed by refluxing the resulting hydroxyamide in xylene. Elaboration of 11 toward our trisubstituted piperidine intermediate now required the addition of a carbon atom and replacement of the ring oxygen by a nitrogen. The first of these goals was achieved by reduction of 11 with diisobutylaluminum hydride to the corresponding lactol, followed by Wittig reaction with methoxymethylene triphenylphosphorane to give 12. Reaction of the latter with diphenylphosphoryl azide20 now converted the liberated primary hydroxyl to an azido group to form 13, from which aqueous acid hydrolysis, in a two-phase system, at room temperature, led to the azido aldehyde 14, in ~60% overall yield from lactone 11.
With the azidoaldehyde 14, we had reached a suitable
intermediate for the construction of the required piperidine. That
construction (Scheme 4) started with the addition of the lithium
salt of 6-methoxy-4-methylquinoline to the carbonyl group of
14 to produce the expected secondary alcohol 15 in ~70% yield.
Alcohol 15 was obtained as a mixture of two epimers, a fact of
no consequence because the mixture was converted by Swern
oxidation to the corresponding azidoketone, the intermediate
we planned to use for cyclization to a piperidine system via an
intramolecular Staudinger reaction.21,22
| Scheme 4 |
We approached the next step with some apprehension because the success of what we intended as a stereospecific synthesis of deoxyquinine depended on the assumption that the specific half-chair conformation which places the vinyl group and the protected hydroxyethyl chain in equatorial orientations (cf. Figure 2) would result, via the anticipated23 axial addition of hydride to an imminium intermediate, in placing the quinolylmethyl substituent in the equatorial orientation corresponding to the specific C-8 configuration required for the eventual deoxyquinine. This proved to be the case: spectral data, especially 13C NMR, showed that the piperidine 18 (7, X = OTBDPS) was produced as a single compound, in 91% yield, by addition of sodium borohydride to a solution of 17 in a 1:1 mixture of tetrahydrofuran and methanol. That the resulting trisubstituted piperidine 18 was the expected correct epimer at C-8 followed from its further conversion to deoxyquinine.
The conversion started (Scheme 5) with the quantitative removal of the silyl protecting group with aqueous hydrogen fluoride in acetonitrile to form 19. We were now ready to close the quinuclidine ring, an operation that required changing the primary hydroxyl into a suitable departing group. On the face of it, that transformation might be expected to require temporary protection of the piperidine amino group, but our previous experience with a somewhat related situation suggested that mesylation-cyclization, directly on 19, could well succeed.24 In fact, treatment of 19 with 1 equiv of mesyl chloride in methylene chloride, in the presence of pyridine, followed by refluxing of the crude product in acetonitrile, afforded, after liberation from the methanesulfonate salt, deoxyquinine (5) in ~70% yield after Flash chromatography.
| Scheme 5 |
The formation of quinine by oxidation of deoxyquinine with
oxygen in tert-butyl alcohol-DMSO, in the presence of
potassium tert-butoxide, proceeded selectively, as had been
found by the Hoffmann-La Roche group. In our hands, a
somewhat higher stereoselectivity (quinine:epiquinine ~14:1)
was obtained by effecting the oxidation in the presence of
sodium hydride in anhydrous DMSO. The synthetic quinine,
thus obtained in 78% yield, had high-resolution mass and 1H
and 13C NMR spectra essentially identical with those of an
authentic sample from Sigma. The melting point and specific
rotation of the monotartrate of our synthetic quinine also agreed
with the reported values: mp 211.0-212.0
C (lit.8f mp 211.0-212.5
C); [
]D21.3 -154.7 (c 0.67, methanol) (lit.8f [
]25D
-156.4 (c 0.97, methanol).
We thank Richard Isaacs and Shino Manabe for their contributions to some aspects of this problem. Financial support was provided by the National Institutes of Health.
Detailed experimental procedures and copies of the 1H NMR and 13C NMR spectra (PDF). This material is available free of charge via the Internet at http://pubs.acs.org.
* In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.
Novartis, Summit, NJ.
Deceased February 17, 1989.
Merck & Co, Rahway, NJ.
University of British Columbia.
1. (a) Turner, R. B.; Woodward, R. B. The Chemistry of the Cinchona
Alkaloids. In The Alkaloids; Manske, R. H. F., Ed.; Academic Press: New
York, 1953; Vol. 3, Chapter 16. (b) Uskokovi
, M. R.; Grethe, G. The
Cinchona Alkaloids. In The Alkaloids; Manske, R. H. F., Ed.; Academic
Press: New York, 1973; Vol. 14, p 181. (c) Grethe, G.; Uskokovi
, M. R.
In The Chemistry of Heterocyclic Compounds; Sexton, J. E., Ed.; Wiley-Interscience: New York, 1983; Vol. 23, Part 4, p 279.
2. (a) McGrew, R. E. The most significant disease for world civilization over the past three centuries. In Encyclopedia of Medical History; McGraw-Hill: New York, 1985; p 166.(b) Casteel, D. A. Quinine may be claimed ··· as the drug to have relieved more human suffering than any other in history. In Burger's Medicinal Chemistry and Drug Discovery, 5th ed.; Wolff, M. E., Ed.; John Wiley: New York, 1997; Vol. 5, Chapter 59, p 16.
3. Over 1 million deaths in 1999; World Health Organization (WHO) Report 2000, World Health in Statistics, Annex Table 3.
4. For a very recent discussion of the status of the malaria problem, see: Science 2000, 290, 428ff.
5. The use of quinine has markedly decreased in recent years, but the U.S. still imported over 68 tons of quinine and its salts in 1999. Cf. U.S. Department of Commerce, U.S. imports of organic chemicals for consumption; Chapter 29, subheading 293921.
6. Rabe, P.; Kindler, K. Chem. Ber. 1918, 51, 466.
7. (a) Woodward, R. B.; Doering, W. E. J. Am. Chem. Soc. 1944, 66,
849.
8. (a) Uskokovi
, M.; Gutzwiller, J.; Henderson, T. J. Am. Chem. Soc.
1970, 92, 203.
, M. J. Am. Chem. Soc. 1970,
92, 204.
(c) Uskokovi
, M.; Reese, C.; Lee, H. L.; Grethe, J.; Gutzwiller,
J. J. Am. Chem. Soc. 1971, 93, 5902.
, M. R. J. Am. Chem. Soc. 1971, 93, 5904.
(e) Grethe, G.; Lee,
H. S.; Mitt, T.; Uskokovi
, M. R. Helv. Chim. Acta 1973, 56, 1485.
(f)
Gutzwiller, J.; Uskokovi
, M. R. Helv. Chim. Acta 1973, 56, 1494.
(g)
Uskokovi
, M. R.; Henderson, T.; Reese, C.; Lee, H. L.; Grethe, J.;
Gutzwiller, J. J. Am. Chem. Soc. 1978, 100, 571.
, M. R. J. Am. Chem. Soc. 1978, 100, 576.
(i) Grethe, G.; Lee,
H. S.; Mitt, T.; Uskokovi
, M. R. J. Am. Chem. Soc. 1978, 100, 581.
(j)
Grethe, G.; Lee, H. S.; Mitt, T.; Uskokovi
, M. R. J. Am. Chem. Soc. 1978,
100, 589.![]()
9. (a) Gates, M.; Sugavanam, B.; Schreiber, W. L. J. Am. Chem. Soc.
1970, 92, 205.
(b) Taylor, E. C.; Martin, S. F. J. Am. Chem. Soc. 1974, 96,
8095.
See also: (c) Speckamp, W. N.; Dijkink, J. Heterocycles 1974, 2,
291.
(d) Brown, R. T.; Curless, D. Tetrahedron Lett. 1986, 27, 6005.![]()
10. Cf. the account presented much later, in his Hofmann Memorial
Lecture, by Perkin: Perkin, W. H. J. Chem. Soc. 1896, 69, 596.
11. Rabe, P.; Ackerman, E.; Schneider, W. Ber. 1907, 40, 3655, and
numerous previous and later papers; cf. ref 1a.
12. (a) Pasteur, L. Compt. rend. 1853, 37, 110.
13. Pro
tenik, M.; Prelog, V. Helv. Chim. Acta 1943, 26, 1965.
14. Woodward and Doering did not claim to have confirmed Rabe's
1918 report, in a few lines, that he had succeeded in converting quinotoxine
to quinine (although the basis of their characterization of Rabe's claim as
"established" is unclear), nor is there any evidence that they produced any
quinine in their own laboratories. But this was wartime, and the U.S. had
been cut off from the Dutch East Indies, its major source of cinchona bark.
The resulting anxiety may explain press accounts, notable for enthusiasm
rather than for sober analysis, which created the quasiuniversal impression
that the construction of homomeroquinene in 1944 meant that quinine had
been synthesized: cf. inter alia: (a) Laurence, W. M. The New York Times,
1944, May 4, 1: "The duplication of the highly complicated chemical
architecture of the quinine molecule, hailed by leading scientists at Harvard
and other institutions as one of the greatest scientific achievements in a
century". (b) Manchester, H. Sci. News Lett. 1944, June 10, 378ff: "Starting
with five pounds of chemical they obtained the equivalent [?] of 40
15. Prelog, V.; Zalan, E. Helv. Chim. Acta 1944, 27, 535.
16. The ingenious, carefully documented,7b separation of the mixture of the cis- and trans-hydroisoquinolone precursors of homomeroquinene is a tribute to the experimental acumen that is also displayed in the further details of the experimental work on the synthesis of homomeroquinene.
17. Stork, G.; McElvain, S. M. J. Am. Chem. Soc. 1946, 68, 1053.
18. Kondo, K.; Mori, E. Chem. Lett. 1974, 741.![]()
19. Ishibashi, F.; Taniguchi, E. Bull. Chem. Soc. Jpn. 1988, 61, 4361.
20. Lal, B.; Pramanik, B. M. I.; Manhas, M. S.; Bose, A. K. Tetrahedron
Lett. 1977, 1977.![]()
21. Inter alia: Knouzi, N.; Vaultier, M.; Carrie, R. Bull. Soc. Chim.
Fr. 1985, 815.
22. For a related sequence, cf.: Pearson, W. H.; Bergmeier, S. C.;
Williams, J. P. J. Org. Chem. 1992, 57, 3977.
23. (a) Valls, J.; Toromanoff, E. Bull. Soc. Chim. Fr. 1961, 758.
(c) Deslongchamps, P.
Stereoelectronic Effects in Organic Chemistry; Pergamon: New York, 1983;
p 211.
24. See also: Narasaka, K.; Yamazaki, S.; Ukaji, Y. Chem. Lett. 1985,
1177.